Inventor

JASSERAND DANIEL

DE17 patents

⚠️ This page may combine multiple inventors who share the name “JASSERAND DANIEL”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

JASSERAND DANIEL

KALI CHEMIE PHARMA GMBH

1,5-Diphenylpyrazolin-3-one compounds, process and intermediates for preparation thereof and pharmaceutical compositions containing same

Antiallergic 5-alkyl-1-phenyl-2-piperazinoalkylpyrazolin-3-one compounds

7-fused 2-(piperazinoalkyl) indole derivatives, intermediates and compositions thereof

1-Phenylindazol-3-one compounds

1-Phenylindazole-3-one compounds, process and intermediates for their preparation, and pharmaceutical compositions containing same

Piperidinoalkylbenzoxazine and piperidinoalkylbenzothiazine compounds, and medicaments containing them

1,5-Diphenyl-2-haloalkylpyrazolin-3-one intermediates

Heterocyclically substituted piperazinoakylbenzoxazine and piperazinoalkylbenzothiazine compounds, processes for preparing them, and medicaments containing them

1,2-dithiol-3-thion-s-oxide compounds and pharmaceutical compositions

SOLVAY PHARM GMBH

11-acetyl-12,13-dioxabicyclo[8.2.1]-tridecenone derivatives, processes for their preparation and pharmaceutical compositions comprising them

Hydronopol derivatives as agonists on human ORL1 receptors

1-amidomethylcarbonyl-piperidine compounds, methods and intermediate products for the production thereof and pharmaceutical formulations containing said compounds

N-triazolylmethyl-piperazine compounds with neurokinin-receptor antagonist activity

Urea derivatives

1-[1-(hetero)aryl-1-perhydroxyalkylmethyl]-piperazine compounds, process for their preparation and pharmaceutical compositions containing them

NK1 and NK2-antagonists and compositions and methods of using the same

SOLVAY PHARM BV

Hydronopol substituted benzimidazolone and quinazolinone derivatives as agonists on human ORL1 receptors